FABP4 is an independent risk factor for lymph node metastasis and poor prognosis in patients with cervical cancer.

Guoqing LiQiulei WuLanqing GongXiaohan XuJing CaiLinjuan XuYa ZengXiaoqi HeZehua Wang

Published in: Cancer cell international (2021)

FABP4 might be a promising biomarker of LNM and survival in patients with early-stage CCa and therefore could significantly contribute to the development of personalized prognosis prediction and therapy optimization.

Keyphrases

poor prognosis
lymph node metastasis
early stage
long non coding rna
binding protein
squamous cell carcinoma
papillary thyroid
free survival
stem cells
lymph node
radiation therapy
cell therapy
neoadjuvant chemotherapy
smoking cessation